Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 9/20 | 0.68 |
| ▸ | HSD17B2 | P37059 | 9/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RXRA | P19793 | 1/20 | 0.50 |
| ▸ | RXRB | P28702 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | ASIC1 | P78348 | 1/20 | 0.49 |
| ▸ | ABL1 | P00519 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4671855 | 0.88 | HSD17B1 (0.68) | HSD17B1HSD17B2CYP3A4CYP2C9ESR1 | |
| SCHEMBL15394543 | 0.86 | KIF11 (0.58) | HSD17B1HSD17B2CYP3A4CYP2C9ESR1 | |
| SCHEMBL19585564 | 0.85 | DHODH (0.56) | HSD17B1HSD17B2CYP3A4CYP2C9LMNA | |
| SCHEMBL25383551 | 0.84 | RXRA (0.59) | HSD17B1HSD17B2CYP3A4CYP2C9ESR1 | |
| SCHEMBL7898375 | 0.82 | HSD17B1 (1.00) | HSD17B1HSD17B2CYP3A4CYP2C9LMNA | |
| SCHEMBL12620498 | 0.81 | LMNA (0.58) | LMNATYRESR1RXRARXRB | |
| SCHEMBL14089413 | 0.81 | ABL1 (0.58) | LMNATYRESR1RXRARXRB | |
| SCHEMBL22793707 | 0.81 | DHODH (0.57) | HSD17B2ESR1RXRARXRBMEN1 | |
| SCHEMBL17105790 | 0.81 | KIF11 (0.68) | HSD17B2RXRARXRBDHODHASIC1 | |
| SCHEMBL967890 | 0.80 | NPC1 (0.54) | HSD17B1HSD17B2LMNACYP1A2OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110065804-A1 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2011-03-17 | — | — | US | claimed |
| WO-2009120784-A2 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2009-10-01 | — | — | WO | claimed |
| WO-2002050002-A1 | NON-HALOGENATED PHENYL SUBSTITUTED PHENOLS, ANTIMICROBIAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | WARNER-LAMBERT COMPANY LLC (US) | 2002-06-27 | — | — | WO | claimed |
| CN-114144420-B | Organic electroluminescent compounds and organic electroluminescent device | SFC株式会社 | 2024-03-26 | — | — | CN | disclosed |
| US-20220271225-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD (KR) | 2022-08-25 | — | — | US | disclosed |
| EP-4006123-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE | SFC Co., Ltd. (KR) | 2022-06-01 | — | — | EP | disclosed |
| EP-4006123-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE | SFC Co., Ltd. (KR) | 2022-06-01 | — | — | EP | disclosed |
| CN-114144420-A | Organic electroluminescent compounds and organic electroluminescent devices | SFC株式会社 | 2022-03-04 | — | — | CN | disclosed |
| WO-2021015417-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE | 에스에프씨 주식회사 | 2021-01-28 | — | — | WO | disclosed |
| US-20190257049-A1 | Methods and Apparatus for Stabilization of Surfaces | Polylast Systems, LLC | 2019-08-22 | — | — | US | disclosed |
| US-10309070-B2 | Methods and apparatus for stabilization of surfaces | Polylast Systems, LLC (US) | 2019-06-04 | — | — | US | disclosed |
| WO-2013106761-A2 | ANTIMICROBIAL AGENTS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-07-18 | — | — | WO | disclosed |
| US-20110065804-A1 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2011-03-17 | — | — | US | disclosed |
| WO-2009120784-A2 | ELECTRODEPOSITED METALLIC FINISHES INCLUDING ANTIMICROBIAL AGENTS | PAVCO INC. (US) | 2009-10-01 | — | — | WO | disclosed |
| US-7557110-B2 | MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine | TEIJIN PHARMA LIMITED (JP) | 2009-07-07 | — | — | US | disclosed |
| US-7557110-B2 | MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine | TEIJIN PHARMA LIMITED (JP) | 2009-07-07 | — | — | US | disclosed |
| US-7211700-B2 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC. (US) | 2007-05-01 | — | — | US | disclosed |
| US-20050239903-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | MCNEIL-PPC, INC | 2005-10-27 | — | — | US | disclosed |
| US-20030207945-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2003-11-06 | — | — | US | disclosed |
| US-20020119106-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | HARPER DAVID SCOTT (US) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030207945-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | HSD17B1 2985/4885HSD17B2 2947/4885CYP3A4 272/4885 |
| US-20220271225-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE | TYR, EED, DDT | HSD17B1 3836/4885HSD17B2 3695/4885CYP3A4 1385/4885 |
| US-20050239903-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | HSD17B1 2985/4885HSD17B2 2947/4885CYP3A4 272/4885 |
| US-20020119106-A1 | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | TYR, CLPP, PTPN1 | HSD17B1 2985/4885HSD17B2 2947/4885CYP3A4 272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.